Skip to main content

Table 5 Unmet coordination needs

From: A survey of cancer patients’ unmet information and coordination needs in handovers – a cross-sectional study

 

Overall unmet coordination needs

Unmet coordination needs in handovers between hospital and GP#

Unmet coordination needs in handovers between internal hospital departments##

Unmet coordination needs at handovers between hospitals###

 

N (%)

OR (95% CI)

ORadja(95% CI)

N (%)

OR (95% CI)

ORadja(95% CI)

N (%)

OR (95% CI)

ORadja(95% CI)

N (%)

OR (95% CI)

ORadja(95% CI)

Demographic characteristics

Gender

 Women

19 (19%)

1.00

1.00

17 (20%)

1.00

1.00

8 (9%)

1.00

1.00

14 (18%)

1.00

1.00

 Men

5 (15%)

0.74 (0.25; 2.18)

1.10 (0.31; 3.93)

4 (13%)

0.63 (0.19; 2.06)

0.88 (0.25; 3.09)

2 (6%)

0.74 (0.15; 3.69)

2.53 (0.37; 17.47)

5 (24%)

1.45 (0.46; 4.62)

1.85a(0.48; 7.07)

Age

 <60 years of age

14 (36%)

1.00

1.00

9 (29%)

1.00

1.00

7 (19%)

1.00

1.00

9 (29%)

1.00

1.00

 ≥60 years of age

10 (11%)

0.22*(0.09; 0.55)

0.26*(0.10; 0.70)

12 (14%)

0.40 (0.15; 1.06)

0.44 (0.16; 1.25)

3 (3%)

0.16*(0.04; 0.65)

0.14*(0.03; 0.68)

10 (14%)

0.41 (0.15; 1.15)

0.46b(0.15; 1.37)

Marital status

 No Partner

5 (18%)

1.00

1.00

3 (12%)

1.00

1.00

2 (7%)

1.00

1.00

4 (18%)

1.00

1.00

 Partner

19 (19%)

1.05 (0.33; 3.13)

1.06 (0.32; 3.50)

18 (20%)

1.81 (0.49; 6.71)

2.05 (0.51; 8.16)

8 (8%)

1.12 (0.22; 5.59)

1.52 (0.24; 9.55)

15 (19%)

1.07 (0.32; 3.63)

0.91c(0.25; 3.28)

Education

 Not higher education

7 (10%)

1.00

1.00

8 (12%)

1.00

1.00

1 (1%)

1.00

1.00

7 (13%)

1.00

1.00

 Higher education

16 (29%)

3.06*(1.36; 9.52)

3.41*(1.23; 9.44)

13 (28%)

2.91*(1.09; 7.73)

2.82*(1.04; 7.63)

9 (17%)

13.02*(1.60; 106.25)

14.22*(1.61; 125.79)

11 (26%)

2.31 (0.81; 6.59)

2.47d(0.82; 7.37)

Clinical characteristics

Comorbidity

 No comorbidity

10 (25%)

1.00

1.00

6 (18%)

1.00

1.00

5 (13%)

1. 00

1.00

7 (21%)

1.00

1.00

 Yes comorbidity

12 (14%)

0.49 (0.19; 1.26)

0.75 (0.26; 2.13)

14 (18%)

0.99 (0.35; 2.84)

1.24 (0.41; 3.80)

5 (6%)

0.44 (0.12; 1.63)

0.83 (0.19; 3.67)

11 (17%)

0.82 (0.28; 2.34)

1.15c(0.35; 3.78)

Treatment

Surgery

 No surgery

3 (9%)

1.00

1.00

5 (16%)

1.00

1.00

2 (6%)

0.55

1.00

3 (14%)

1.00

1.00

 Surgery

21 (22%)

2.89 (0.80; 10.41)

2.98 (0.35; 25.77)

16 (19%)

1.27 (0.42; 3.81)

0.37 (0.05; 3.04)

8 (9%)

1.43 (0.29; 7.08)

0.63 (0.04; 9.04)

16 (21%)

1.55 (0.41; 5.91)

6.06c(0.33; 110.58)

Radiation

 No radiation

9 (18%)

1.00

1.00

6 (13%)

1.00

1.00

4 (8%)

1.00

1.00

7 (27%)

1.00

1.00

 Radiation

15 (19%)

1.09 (0.44; 2.73)

1.26 (0.44; 3.56)

15 (21%)

1.74 (0.62; 4.88)

1.80 (0.60; 5.42)

6 (8%)

0.96 (0.26; 3.58)

1.14 (0.26; 5.01)

12 (16%)

0.53 (0.18; 1.55)

0.57c(0.18; 1.82)

Chemotherapy

 No chemotherapy

8 (13%)

1.00

1.00

7 (12%)

1.00

1.00

4 (7%)

1.00

1.00

10 (23%)

1.00

1.00

 Chemotherapy

16 (24%)

2.08 (0.82; 5.27)

1.10 (0.30; 4.06)

14 (24%)

2.22 (0.82; 6.00)

1.91 (0.49; 7.44)

6 (9%)

1.35 (0.36; 5.04)

0.54 (0.07; 4.17)

9 (16%)

0.67 (0.24; 1.82)

0.34c(0.08; 1.38)

Hormones

 No hormones

9 (30%)

1.00

1.00

9 (38%)

1.00

1.00

2 (7%)

1.00

1.00

5 (23%)

1.00

1.00

 Hormones

15 (15%)

0.41 (0.16; 1.07)

0.45 (0.15; 1.33)

12 (13%)

0.25*(0.09; 0.70)

0.21*(0.07; 0.66)

8 (8%)

1.24 (0.25; 6.20)

1.39 (0.23; 8.55)

14 (18%)

0.75 (0.24; 2.39)

0.87c(0.24; 3.11)

Years since diagnosis

 <3 years

12 (20%)

1.00

1.00

11 (22%)

1.00

1.00

6 (10%)

1.00

1.00

8 (17%)

1.00

1.00

 ≥3 years

12 (17%)

0.83 (0.34; 2.01)

0.99 (0.35; 2.78)

10 (15%)

0.66 (0.26; 1.71)

0.61 (0.21; 1.76)

4 (6%)

0.56 (0.15; 2.10)

0.73 (0.16; 3.38)

11 (22%)

1.38 (0.50; 3.38)

1.98c(0.63; 6.25)

  1. aAdjusted for age, gender and education, *P < 0.050, #Consists of 117 patient responses, ##Consists of 125 patient responses, ###Consists of 100 patient responses.